Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $4.0 million.

  • Organogenesis Holdings' Depreciation and Depletion rose 1285.71% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 1410.32%. This contributed to the annual value of $13.6 million for FY2024, which is 3038.86% up from last year.
  • Per Organogenesis Holdings' latest filing, its Depreciation and Depletion stood at $4.0 million for Q3 2025, which was up 1285.71% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Depreciation and Depletion registered a high of $4.0 million during Q3 2025, and its lowest value of $1.0 million during Q1 2021.
  • In the last 5 years, Organogenesis Holdings' Depreciation and Depletion had a median value of $2.5 million in 2023 and averaged $2.5 million.
  • In the last 5 years, Organogenesis Holdings' Depreciation and Depletion tumbled by 2483.22% in 2022 and then soared by 10000.0% in 2023.
  • Organogenesis Holdings' Depreciation and Depletion (Quarter) stood at $1.8 million in 2021, then dropped by 14.51% to $1.5 million in 2022, then skyrocketed by 96.96% to $3.0 million in 2023, then grew by 21.23% to $3.6 million in 2024, then grew by 11.45% to $4.0 million in 2025.
  • Its Depreciation and Depletion was $4.0 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.4 million in Q1 2025.